Determination and diagnostic value of CA9 mRNA in peripheral blood of patients with oral leukoplakia

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Cirurxía e Especialidades Médico-Cirúrxicas
dc.contributor.authorTorres López, Manuel
dc.contributor.authorPérez-Sayáns García, Mario
dc.contributor.authorChamorro Petronacci, Cintia
dc.contributor.authorBarros Angueira, Francisco
dc.contributor.authorGándara Vila, Pilar
dc.contributor.authorLorenzo Pouso, Alejandro
dc.contributor.authorGarcía García, Abel
dc.date.accessioned2026-04-27T08:13:35Z
dc.date.available2026-04-27T08:13:35Z
dc.date.issued2018-12
dc.description.abstractBackground: Oral leukoplakia is one of the most common oral premalignant disorder. The classical evaluation through tissue biopsy is not always valid to evaluate the risk of malignization. Material and methods: RT-qPCR was performed on 47 blood samples (21 patients with leukoplakia, 2 with oral squamous cell carcinoma (OSCC), and 24 healthy patients) and on 11 tissue samples (3 leukoplakia, 4 OSCC, and 4 samples of healthy tissue). Results: There are significant differences in expression between the different groups (F = 4.057, p = .006). The Duncan post hoc test shows that the only group that differentiates is the tumour tissue. Using Wilcoxon test, different covariables of patients with leukoplakia were analysed with respect to the group of healthy patients and no significant differences were observed. Conclusions: The diagnostic route through liquid biopsy has not been conclusive in this study, but there are significant differences in the levels analysed in the different tissue samples.
dc.description.peerreviewedSI
dc.identifier.citationTorres López, M., Pérez Sayáns, M., Chamorro Petronacci, C., Barros Angueira, F., Gándara Vila, P., Lorenzo Pouso, A., & García García, A. (2018). Determination and diagnostic value of CA9 mRNA in peripheral blood of patients with oral leukoplakia. Journal of Enzyme Inhibition and Medicinal Chemistry, 33(1), 951–955. https://doi.org/10.1080/14756366.2018.1466120
dc.identifier.doi10.1080/14756366.2018.1466120
dc.identifier.essn1475-6374
dc.identifier.issn1475-6366
dc.identifier.urihttps://hdl.handle.net/10347/46981
dc.issue.number1
dc.journal.titleJournal of enzyme inhibition and medicinal chemistry
dc.language.isoeng
dc.page.final955
dc.page.initial951
dc.publisherTaylor & Francis
dc.relation.publisherversionhttps://doi.org/10.1080/14756366.2018.1466120
dc.rights© 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCA9
dc.subjectOral squamous cell carcinoma
dc.subjectLeukoplakia
dc.titleDetermination and diagnostic value of CA9 mRNA in peripheral blood of patients with oral leukoplakia
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number33
dspace.entity.typePublication
relation.isAuthorOfPublication1fc179e1-51df-42a8-8961-420b8d496a9e
relation.isAuthorOfPublicationfba09624-8717-4db3-afdd-e018d34469f3
relation.isAuthorOfPublicationaa8969d9-de9f-4f24-8b2d-09e3e33313f9
relation.isAuthorOfPublication.latestForDiscovery1fc179e1-51df-42a8-8961-420b8d496a9e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018_journal_perez_determination.pdf
Size:
1.67 MB
Format:
Adobe Portable Document Format